MedPath

To decrease anxiety in children before shifting to operating room by giving nebulization

Phase 2
Not yet recruiting
Conditions
Medical and Surgical, (2) ICD-10 Condition: K469||Unspecified abdominal hernia without obstruction or gangrene,
Registration Number
CTRI/2021/11/038074
Lead Sponsor
Dr Aathira das
Brief Summary

The study is  a randomized, double-blinded study .

This  study is designed to evaluate and compare the efficacy and safety of nebulized  dexmedetomidine, nebulized  ketamine, and nebulized  fentanyl as a premedication prior to general anaesthesia (GA) in paediatric patients. All patients who are allergic to the drugs used in this study ,Congenital heart disease,developmental delay and parental refusal are excluded from the study.Study will be done in 3-8 years of age group.

Patients will be randomly categorized into 3 equal groups (30 each) using a random numbers table with group allocation concealed in sealed opaque envelopes. Group K patients will be premedicated with nebulized ketamine solution (2 mg/kg), group D patients will be premedicated with nebulized dexmedetomidine solution (2 μg/kg), and group F will be premedicated with nebulized fentanyl(2mcg/kg).The observers and attending anaesthesiologists will be blinded to the drug being administered. A researcher who will not participate in the evaluation will administer the drugs to all the children in nebuliser.

OUTCOMES:

1) The primary end point is the degree of sedation when the child was first seen in the OR 30 minutes after sedation, based on the Ramsay Sedation Scale..

2) The secondary end points are parental separation, perioperative HR and BP, hemodynamic changes, sedation at emergence,post operative Face ,Legs ,Activity, Cry ,Consolability (FLACC) pain scale, the incidence of Emergence Agitation (EA),adverse effects.

REFERENCES

1. Kain ZN, Caldwell-Andrews AA, Krivutza DM, Weinberg ME, Wang SM, Gaal D. Trends in the practice of parental presence during induction of anesthesia and the use of preoperative sedative premedication in the United States, 1995-2002: results of a follow-up national survey. Anesth Analg. 2004;98:1252–9

2. Hosey MT, Macpherson LM, Adair P, Tochel C, Burnside G, Pine C. Dental anxiety, distress at induction and postoperative morbidity in children undergoing tooth extraction using general anaesthesia. Br Dent J. 2006;200:39–43

3. Hosey MT, Asbury AJ, Bowman AW, Millar K, Martin K, Musiello T, Welbury R. The effect of transmucosal 0.2 mg/kg midazolam premedication on dental anxiety, anaesthetic induction and psychological morbidity in children undergoing general anaesthesia for tooth extraction. Br Dent J. 2009;207:E2

4.Kain ZN, Caldwell-Andrews AA, Maranets I, McClain B, Gaal D, Mayes LC, Feng R, Zhang H. Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth Analg. 2004;99:1648–54 6. Warrington SE, Kuhn RJ. Use of intranasal medications in pediatric patients. Orthopedics. 2011;34:456–9

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

parents consent 2.age group 3-8 yrs 3.type of surgery included:infraumbilical surgery 4.ASA physical status 1 and 2.

Exclusion Criteria
  • 1.Parents refusal 2.All patients who have history of allergies to any of the drugs used in the study.
  • 3.Congenital disease 4 Developmental delay.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of sedation when the child first seen in the OR 30 min after sedation based on Ramsay sedation scale.30 min
Secondary Outcome Measures
NameTimeMethod
Parental seperation ,perioperative HR and BP,hemodynamical changes,sedation at emergence,post operative Face,Legs,Activity,Cry,Consolobility(FLACC) pain scale,the incidence of emergence agitation (EA),adverse events.perioperative assessment:0,5,10,20,30 min

Trial Locations

Locations (1)

Rajendra institute of medical sciences

🇮🇳

Ranchi, JHARKHAND, India

Rajendra institute of medical sciences
🇮🇳Ranchi, JHARKHAND, India
DR Aathira das
Principal investigator
9447736160
aathiradas83@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.